* Sixty-three patients on SNRIs (venlafaxine, duloxetine) and sixty patients on SSRIs underwent assessments, showing that SSRI users had lower bone density values compared to SNRI users, who demonstrated normal bone density.
* The findings suggest that SNRIs, particularly duloxetine, may pose a lower risk for osteoporosis compared to SSRIs, indicating the need for more research to confirm these results.